| Rapid COVID-19 vaccine development #MMPMID32385100Graham BSScience 2020[May]; 368 (6494): 945-946 PMID32385100show ga
ä|*Viral Vaccines/adverse effects/immunology[MESH]|Animals[MESH]|Antibodies, Neutralizing/biosynthesis/immunology[MESH]|Antibodies, Viral/biosynthesis/immunology[MESH]|Antibody-Dependent Enhancement[MESH]|Betacoronavirus/*immunology/physiology[MESH]|COVID-19[MESH]|COVID-19 Vaccines[MESH]|Coronavirus Infections/immunology/*prevention & control[MESH]|Cytokines/immunology[MESH]|Disease Models, Animal[MESH]|Humans[MESH]|Pandemics/*prevention & control[MESH]|Pneumonia, Viral/immunology/*prevention & control[MESH]|SARS-CoV-2[MESH]|T-Lymphocytes/immunology[MESH]
DeepDyve Pubget Overpricing |
|